Rare diseases
Investigational molecules
Locations
855 Oak Grove Avenue Suite 100, 94025-4429, United States
Oruka Therapeutics Inc. focuses its clinical research on moderate-to-severe plaque psoriasis, with attention to treatment options for chronic inflammatory skin disease and visible cutaneous symptoms.
The sponsor’s active research interest centers on therapeutic development for patients with persistent psoriatic disease requiring systemic management.
Oruka Therapeutics Inc. runs clinical trials in conditions such as Psoriasis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Long-term Safety and Efficacy of ORKA-001 in Adults with Moderate-to-Severe Plaque Psoriasis (Open-Label Extension Study)
GermanyORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
